Activity — Li Dean Y
6 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 26, 2026 | Grant | MRK Merck & Co., Inc. Common Stock | $2.20M | +20K +25.02% | 102,270 <0.01% of shares | low |
| Feb 4, 2026 | Sell | MRK Merck & Co., Inc. Common Stock | $1.79M | -15K -12.86% | 102,270 <0.01% of shares | medium |
| Feb 10, 2026 | Sell | MRK Merck & Co., Inc. Common Stock | $1.20M | -10K -10.01% | 92,035 <0.01% of shares | medium |
| Feb 4, 2026 | Exercise | MRK Merck & Co., Inc. Common Stock | $845.5K | +15K +14.75% | 117,357 <0.01% of shares | low |
| Jan 2, 2026 | Grant | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $0 | +2K +0.19% | 1,240,909 0.23% of shares | low |
| Feb 4, 2026 | Exercise | MRK Merck & Co., Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |